Anti-TNF-Alpha-Induced Psoriasis – An Unusual Paradox

Anti-TNF-α agents are currently utilised for the treatment of a vast array of autoimmune conditions including inflammatory bowel disease, rheumatoid arthritis, ankylosing spondylitis and psoriasis. It is however noted that such therapeutic strategies have been linked to the specific induction of cut...

Full description

Bibliographic Details
Main Authors: Neel Sharma, James Lindsay
Format: Article
Language:English
Published: Karger Publishers 2009-11-01
Series:Case Reports in Gastroenterology
Subjects:
Online Access:http://www.karger.com/Article/FullText/257907
id doaj-9139b6b916ee4fa991dba4a377ec1265
record_format Article
spelling doaj-9139b6b916ee4fa991dba4a377ec12652020-11-25T01:48:48ZengKarger PublishersCase Reports in Gastroenterology1662-06312009-11-013340440710.1159/000257907257907Anti-TNF-Alpha-Induced Psoriasis – An Unusual ParadoxNeel SharmaJames LindsayAnti-TNF-α agents are currently utilised for the treatment of a vast array of autoimmune conditions including inflammatory bowel disease, rheumatoid arthritis, ankylosing spondylitis and psoriasis. It is however noted that such therapeutic strategies have been linked to the specific induction of cutaneous-based reactions such as dermatitis, erythema multiforme and psoriasis. Here we present the case of a young female patient with Crohn’s disease who developed psoriasis following treatment with the anti-TNF-α drug adalimumab and highlight the possible pathogenetic mechanisms involved in such an occurrence.http://www.karger.com/Article/FullText/257907Anti-TNF-alphaPsoriasisCrohn’s disease
collection DOAJ
language English
format Article
sources DOAJ
author Neel Sharma
James Lindsay
spellingShingle Neel Sharma
James Lindsay
Anti-TNF-Alpha-Induced Psoriasis – An Unusual Paradox
Case Reports in Gastroenterology
Anti-TNF-alpha
Psoriasis
Crohn’s disease
author_facet Neel Sharma
James Lindsay
author_sort Neel Sharma
title Anti-TNF-Alpha-Induced Psoriasis – An Unusual Paradox
title_short Anti-TNF-Alpha-Induced Psoriasis – An Unusual Paradox
title_full Anti-TNF-Alpha-Induced Psoriasis – An Unusual Paradox
title_fullStr Anti-TNF-Alpha-Induced Psoriasis – An Unusual Paradox
title_full_unstemmed Anti-TNF-Alpha-Induced Psoriasis – An Unusual Paradox
title_sort anti-tnf-alpha-induced psoriasis – an unusual paradox
publisher Karger Publishers
series Case Reports in Gastroenterology
issn 1662-0631
publishDate 2009-11-01
description Anti-TNF-α agents are currently utilised for the treatment of a vast array of autoimmune conditions including inflammatory bowel disease, rheumatoid arthritis, ankylosing spondylitis and psoriasis. It is however noted that such therapeutic strategies have been linked to the specific induction of cutaneous-based reactions such as dermatitis, erythema multiforme and psoriasis. Here we present the case of a young female patient with Crohn’s disease who developed psoriasis following treatment with the anti-TNF-α drug adalimumab and highlight the possible pathogenetic mechanisms involved in such an occurrence.
topic Anti-TNF-alpha
Psoriasis
Crohn’s disease
url http://www.karger.com/Article/FullText/257907
work_keys_str_mv AT neelsharma antitnfalphainducedpsoriasisanunusualparadox
AT jameslindsay antitnfalphainducedpsoriasisanunusualparadox
_version_ 1725010081153548288